The Journey from Pain to Relief: Unraveling the Genetics of Addiction

‍

Opioid addiction is a complex issue that is steeply rooted in our genetic framework. Genetic mutations, although random, sometimes give us pleasure and sometimes bring harm. We have no control over which ones we inherit, but the advancements of modern science have allowed us to use these mutations to transition from debilitating pain to relief.

‍

Unmasking the Role of Endorphins in Opioid Addiction

One approach to opioid addiction treatment, Medications for Opioid Use Disorder (MOUD), aims to administer a normalizing dose of Methadone or Buprenorphine to an individual suffering from opioid dependency. This approach rests on the belief that these individuals might be grappling with an 'endorphin deficiency'. There's compelling evidence that an attraction to opioids can either result from or lead to this condition after repeated exposure to opioids due to a myriad of stress-related reasons.

‍

Alcohol: An Apt Comparison

Drawing parallels between opioid addiction and alcohol use might help us understand this matter better. The influence of genetic mutations in our propensity to consume and become addicted to alcohol is a topic of ongoing scholarly debate. Similarly, those who inherit an excess or deficiency of opioid-related genes may experience either a compelling attraction or an intense repulsion to opioids.

‍

Our Historical Tryst with Opioids

The human relationship with opioids, like opium derivatives, is age-old, highlighting the long-standing presence of opioid receptors in the brain. These receptors control critical functions, like pain control, anxiety reduction, and even influence the size of our pupils. Interestingly, the opioid receptors in the reward areas of our brain are densely populated, underscoring the role of opioids in our pleasure-seeking behaviors.

‍

Understanding the Role of Endorphins

Endorphins, discovered in the early 1970s, are short proteins that interact with the opioid receptors quickly. They're broken down almost immediately, protecting us from developing an addiction to them. However, opioids amplify the effects of endorphins but are not broken down as rapidly. They adhere to the receptors for a more extended period than endorphins. Over time, this behavior of opioids leads to the development of tolerance and a possible 'endorphin deficiency'.

‍

Future of Addiction Treatment: Gene Mapping

Today, as more people participate in gene mapping programs like '23 and Me' and 'Ancestry DNA', we're gathering substantial data to understand genetic variations better. With this wealth of information, it's plausible that in the future, we could manipulate genetic mutations to treat drug addictions effectively.

‍

Methadone and Buprenorphine: Correcting Endorphin Deficiency

Both Methadone and Buprenorphine have shown promising results in restoring normal consciousness and physiology in individuals grappling with opioid addiction. Just as a medication like Atorvastatin can effectively manage high cholesterol, Methadone and Buprenorphine can normalize the conditions for those with opioid dependency, reducing or eliminating the associated stigma and paving the path towards a healthier life.

If you're seeking effective treatment for opioid addiction in Sacramento, our dedicated team at our opioid addiction treatment clinic can provide personalized, compassionate care. We believe in utilizing science-backed approaches, like MOUD, to ensure you or your loved one can live a life free from the clutches of addiction. Contact us today to begin your journey to recovery.

‍